Total Funding
61
48
Total FundingGrant raised
Growth Score
-6 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
137214
GID BIO, Inc.’s platform enables cell-based treatments for a broad range of therapies utilizing a patients' own cells.
- Patrick Maxwell: Founder
Adam Katz: Founder, DirectorPast Role: PluroGen Therapeutics, Founder
About the Company
GID BIO, Inc. is a global leader in cellular therapy, offering a tissue processing platform that enables cell-based treatments for a broad range of therapies. Our team of seasoned executives, adipose tissue scientists and surgeons works together to discover reliable, cost-effective solutions that utilize patients' own cells as a treatment
option.
The company was formerly known as The GID Group. It was incorporated in 2008 and is based in Louisville Colorado.
